Palmitoleic Acid

Palmitoleic Acid

SCHEMBL4920934

CCCCCC/C=C\CCCCCCCC(=O)[O-].[K+]

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Palmitoleic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 9/20 1.00
TERT O14746 2/20 0.66
GMNN O75496 1/20 0.66
USP2 O75604 1/20 0.66
LMNA P02545 1/20 0.66
CYP1A2 P05177 1/20 0.66
POLB P06746 1/20 0.66
MAPT P10636 1/20 0.66
CYP2C9 P11712 1/20 0.66
ALOX15 P16050 1/20 0.66
APEX1 P27695 1/20 0.66
CYP2C19 P33261 1/20 0.66
RECQL P46063 1/20 0.66
BLM P54132 1/20 0.66
NPSR1 Q6W5P4 1/20 0.66
HSD17B10 Q99714 1/20 0.66
DUSP3 P51452 1/20 0.66
MMP2 P08253 1/20 0.66
FABP4 P15090 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oleic Acid SCHEMBL36769 1.00 FABP3 (1.00) FABP3TERTGMNNUSP2LMNA
Oleic Acid SCHEMBL2771497 1.00 FABP3 (1.00) FABP3TERTGMNNUSP2LMNA
Vaccenic Acid SCHEMBL18094457 1.00 FABP3 (1.00) FABP3TERTGMNNUSP2LMNA
Oleic Acid SCHEMBL36767 1.00 FABP3 (1.00) FABP3TERTGMNNUSP2LMNA
Oleic Acid SCHEMBL1332808 1.00 FABP3 (1.00) FABP3TERTGMNNUSP2LMNA
Oleic Acid SCHEMBL2771494 1.00 FABP3 (1.00) FABP3TERTGMNNUSP2LMNA
Oleic Acid SCHEMBL8991986 1.00 FABP3 (1.00) FABP3TERTGMNNUSP2LMNA
Palmitoleic Acid SCHEMBL4920942 1.00 FABP3 (1.00) FABP3TERTGMNNUSP2LMNA
Vaccenic Acid SCHEMBL18094456 1.00 FABP3 (1.00) FABP3TERTGMNNUSP2LMNA
Nervonic Acid SCHEMBL18094452 1.00 FABP3 (1.00) FABP3TERTGMNNUSP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115554178-B Moisturizing cleansing foam composition and preparation method and application thereof 广州极男化妆品有限公司 2024-04-19 CN claimed
CN-112481621-B Metal cleaning agent and preparation method thereof 德旭新材料(佛冈)有限公司 2023-07-25 CN claimed
CN-109563439-B Cleaning composition 因诺斯佩克活性化学物有限责任公司 2021-10-12 CN claimed
US-20260130369-A1 MARINE ALGICIDES MOTE MARINE LABORATORY INC (US) 2026-05-14 US disclosed
EP-4692260-A1 KIT FOR THREE-COMPONENT COATING COMPOSITION, THREE-COMPONENT COATING COMPOSITION, AND IN-MOLD COATING METHOD Kansai Paint Co., Ltd (JP) 2026-02-11 EP disclosed
US-20260021615-A1 COATING COMPOSITION AND IN-MOLD COATING METHOD KANSAI PAINT CO LTD (JP) 2026-01-22 US disclosed
US-12485593-B2 Method for forming in-mold coating multi-layer coating film KANSAI PAINT CO., LTD. (JP) 2025-12-02 US disclosed
EP-3728487-B1 METHOD OF REMOVING POLYMERIC MATERIAL COMPRISING HETEROATOMS FROM A SURFACE USING COMPOSITIONS INCLUDING A KETO-ESTER COMPOUND FOURTH PRINCIPLE LLC (US) 2025-07-02 EP disclosed
US-12325805-B2 Coating composition and in-mold coating method KANSAI PAINT CO., LTD. (JP) 2025-06-10 US disclosed
US-20250144859-A1 METHOD FOR FORMING IN-MOLD COATING MULTI-LAYER COATING FILM KANSAI PAINT CO., LTD. (JP) 2025-05-08 US disclosed
WO-2025070002-A1 COATING MATERIAL COMPOSITION AND IN-MOLD COATING METHOD 関西ペイント株式会社 2025-04-03 WO disclosed
US-9005884-B2 Developer composition for printing plate, developer and method for manufacturing printing plate TOYOBO CO., LTD. (JP) 2015-04-14 US disclosed
EP-2751209-A1 METHODS OF PRODUCING A TITANIUM DIOXIDE PIGMENT AND IMPROVING THE PROCESSABILITY OF TITANIUM DIOXIDE PIGMENT PARTICLES Tronox LLC (US) 2014-07-09 EP disclosed
US-8663518-B2 Methods of producing a titanium dioxide pigment and improving the processability of titanium dioxide pigment particles TRONOX LLC (US) 2014-03-04 US disclosed
EP-2677365-A1 PRINTING PLATE DEVELOPING SOLUTION COMPOSITION, DEVELOPING SOLUTION, AND METHOD OF MANUFACTURING PRINTING PLATE PRECURSOR Toyobo Co., Ltd. (JP) 2013-12-25 EP disclosed
US-20130288185-A1 DEVELOPER COMPOSITION FOR PRINTING PLATE, DEVELOPER AND METHOD FOR MANUFACTURING PRINTING PLATE TOYOBO CO., LTD. (JP) 2013-10-31 US disclosed
WO-2013101838-A1 METHODS OF PRODUCING A TITANIUM DIOXIDE PIGMENT AND IMPROVING THE PROCESSABILITY OF TITANIUM DIOXIDE PIGMENT PARTICLES TRONOX LLC (US) 2013-07-04 WO disclosed
US-20130161856-A1 METHODS OF PRODUCING A TITANIUM DIOXIDE PIGMENT AND IMPROVING THE PROCESSABILITY OF TITANIUM DIOXIDE PIGMENT PARTICLES TRONOX LLC (US) 2013-06-27 US disclosed
US-20080061270-A1 Oxygen-Absorbing Composition And Packaging Material KURARAY CO., LTD (JP) 2008-03-13 US disclosed
EP-1769845-A1 OXYGEN-ABSORBING COMPOSITION AND PACKAGING MATERIAL Kuraray Co., Ltd. (JP) 2007-04-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260130369-A1 MARINE ALGICIDES SLC6A13, HABP2, SLC27A2 FABP3 504/4885TERT 4166/4885GMNN 4499/4885
US-20260021615-A1 COATING COMPOSITION AND IN-MOLD COATING METHOD VIM, VCL, C9 FABP3 4730/4885TERT 2072/4885GMNN 1028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.